
### [NCIT:C6605](http://purl.obolibrary.org/obo/NCIT_C6605)
**Label:** Soft Tissue Fibrosarcoma

**Subclasses:** [NCIT:C7726](http://purl.obolibrary.org/obo/NCIT_C7726) (Kidney Fibrosarcoma), [NCIT:C49024](http://purl.obolibrary.org/obo/NCIT_C49024) (Low Grade Myofibroblastic Sarcoma), [NCIT:C5336](http://purl.obolibrary.org/obo/NCIT_C5336) (Small Intestinal Fibrosarcoma), [NCIT:C5832](http://purl.obolibrary.org/obo/NCIT_C5832) (Liver Fibrosarcoma), [NCIT:C5233](http://purl.obolibrary.org/obo/NCIT_C5233) (Ovarian Fibrosarcoma), [NCIT:C45202](http://purl.obolibrary.org/obo/NCIT_C45202) (Low Grade Fibromyxoid Sarcoma), [NCIT:C5465](http://purl.obolibrary.org/obo/NCIT_C5465) (Central Nervous System Fibrosarcoma), [NCIT:C5185](http://purl.obolibrary.org/obo/NCIT_C5185) (Breast Fibrosarcoma), [NCIT:C5361](http://purl.obolibrary.org/obo/NCIT_C5361) (Cardiac Fibrosarcoma), 

**Class expressions from DL-Learner:**

- Thing 53.20%
- [CL:0000057](http://purl.obolibrary.org/obo/CL_0000057) (fibroblast) 53.12%
- [NCIT:C49028](http://purl.obolibrary.org/obo/NCIT_C49028) (Malignant Fibroblast) 38.48%
- [NCIT:C49028](http://purl.obolibrary.org/obo/NCIT_C49028) (Malignant Fibroblast) and (not ([NCIT:C40318](http://purl.obolibrary.org/obo/NCIT_C40318) (Vulvar Leiomyosarcoma))) 38.48%
- [NCIT:C49028](http://purl.obolibrary.org/obo/NCIT_C49028) (Malignant Fibroblast) and (not ([NCIT:C40314](http://purl.obolibrary.org/obo/NCIT_C40314) (Vulvar Trichoepithelioma))) 38.48%
- [NCIT:C49028](http://purl.obolibrary.org/obo/NCIT_C49028) (Malignant Fibroblast) and (not ([NCIT:C40312](http://purl.obolibrary.org/obo/NCIT_C40312) (Vulvar Nodular Hidradenoma))) 38.48%
- [NCIT:C49028](http://purl.obolibrary.org/obo/NCIT_C49028) (Malignant Fibroblast) and (not ([NCIT:C40311](http://purl.obolibrary.org/obo/NCIT_C40311) (Vulvar Syringoma))) 38.48%
- [NCIT:C49028](http://purl.obolibrary.org/obo/NCIT_C49028) (Malignant Fibroblast) and (not ([NCIT:C40309](http://purl.obolibrary.org/obo/NCIT_C40309) (Vulvar Sebaceous Carcinoma))) 38.48%
- [NCIT:C49028](http://purl.obolibrary.org/obo/NCIT_C49028) (Malignant Fibroblast) and (not ([NCIT:C40308](http://purl.obolibrary.org/obo/NCIT_C40308) (Vulvar Apocrine Adenocarcinoma))) 38.48%
- [NCIT:C49028](http://purl.obolibrary.org/obo/NCIT_C49028) (Malignant Fibroblast) and (not ([NCIT:C40307](http://purl.obolibrary.org/obo/NCIT_C40307) (Vulvar Clear Cell Hidradenocarcinoma))) 38.48%
- [NCIT:C49028](http://purl.obolibrary.org/obo/NCIT_C49028) (Malignant Fibroblast) and (not ([NCIT:C40306](http://purl.obolibrary.org/obo/NCIT_C40306) (Vulvar Eccrine Porocarcinoma))) 38.48%
- [NCIT:C49028](http://purl.obolibrary.org/obo/NCIT_C49028) (Malignant Fibroblast) and (not ([NCIT:C40301](http://purl.obolibrary.org/obo/NCIT_C40301) (Adenoma of Minor Vestibular Glands))) 38.48%
- [NCIT:C49028](http://purl.obolibrary.org/obo/NCIT_C49028) (Malignant Fibroblast) and (not ([NCIT:C40299](http://purl.obolibrary.org/obo/NCIT_C40299) (Bartholin Gland Adenoma))) 38.48%
- [NCIT:C49028](http://purl.obolibrary.org/obo/NCIT_C49028) (Malignant Fibroblast) and (not ([NCIT:C40298](http://purl.obolibrary.org/obo/NCIT_C40298) (Bartholin Gland Small Cell Carcinoma))) 38.48%
- [NCIT:C49028](http://purl.obolibrary.org/obo/NCIT_C49028) (Malignant Fibroblast) and (not ([NCIT:C40297](http://purl.obolibrary.org/obo/NCIT_C40297) (Bartholin Gland Transitional Cell Carcinoma))) 38.48%


